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development and production of adipocytes (Rosen
et al., 2000), their exact role in synaptic plasticity is still
a mystery, and a limited number of C/EBP target genes
have been identified in neurons (for a review see Ramji
and Foka, 2002).
The C/EBPb message and protein are both increased
in the hippocampus following hippocampus-dependent
learning (Taubenfeld et al., 2001b). Moreover, inhibition
of C/EBPb expression in the hippocampus by adminis-
tration of antisense oligonucleotides has been reported
to cause severe deficits in hippocampus-dependent
memory in mice (Taubenfeld et al., 2001a). Because
the administration of CRE oligonucleotide decoys com-
pletely blocks expression of C/EBPb during training for
contextual memory, increased expression is thought
to be mediated through CRE-mediated transcription
(Athos et al., 2002). The discovery that ApLLP is required
for LTF and functions as a link between serotonin acti-
vation of adenylyl cyclase and C/EBP expression is an
intriguing discovery that underscores the potential im-
portance of this novel protein in the C/EBP signaling
cascade.
C/EBP has been implicated in synaptic plasticity in
both vertebrates and invertebrates using a variety of
technologies. The signaling pathway in Aplysia is sche-
matically illustrated in Figure 1. It remains to be seen
whether a similar nucleolar mechanism exists in mam-
malian systems, and this will clearly be an important
area of investigation in the future. Other questions re-
main as well. For example, how does cAMP signaling
regulate ApLLP expression? Is the nucleolar localization
of ApLLP significant for its pivotal role in the induction
of LTF? More broadly, how does an increase in C/EBP
protein contribute to long-term changes in synaptic
strength during synaptic potentiation? The results of
Kim and colleagues are provocative and provide the
field with many new avenues to pursue in the future.
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Transient Forebrain Ischemia
A molecular explanation for why some neurons are
more vulnerable than others to ischemic injury has
long remained elusive. In this issue of Neuron, Peng
et al. propose that CREB-dependent downregulation
of the RNA editing enzyme ADAR2, resulting in defec-
tive Q/R editing of AMPA receptor GluR2 subunits and
increased availability of calcium and zinc-permeable
death-promoting AMPA receptors, underlies the vul-
nerability of some neuronal populations to ischemia.
Stroke, because of occlusion or rupture of an artery, is
a leading cause of death or infirmity in developed coun-
tries. In stroke, lack of blood flow to the brain (ischemia)
results in excessive release of the neurotransmitter glu-
tamate into the extracellular space. For over two de-
cades, it has been known that this glutamate release ac-
tivates ionotropic glutamate receptors, causing calcium
entry, excitotoxicity, and neuronal death in vulnerable
brain regions (Simon et al., 1984; Szatkowski and
Attwell, 1994; Lo et al., 2003). What has thus far re-
mained less clear is the specific role of different types
of Ca2+-permeable glutamate receptor in precipitating
cell death and why neurons in some regions of the brain,
including hippocampal CA1 pyramidal neurons, striatal
spiny neurons, and cortical projection neurons, are
more vulnerable to glutamate mediated excitotoxicity
(Simon et al., 1984; Pellegrini-Giampietro et al., 1997;
Lo et al., 2003).
In the central nervous system (CNS), activation of ion-
otropic glutamate receptors allows a rapid influx of
ions across the neuronal membrane, mediating fast
excitatory synaptic transmission. Ionotropic glutamate
receptors are also critical for synaptic plasticity and
learning and memory. However, excessive activation of
glutamate receptors in pathological conditions, such as
anoxia or ischemia, precipitates excitotoxic neuronal
death in vulnerable neuronal types by allowing an exces-
sive influx of Ca2+, Na+, and Zn2+ ions into the cell (Lo
et al., 2003). There are three main classes of ionotropic
glutamate receptor: NMDA, AMPA, and kainate recep-
tors. Because all NMDA receptors are permeable to cal-
cium, initial studies focused on the role of these recep-
tors in ischemic injury (Simon et al., 1984; Lo et al.,
2003). More recently, however, attention has turned to
a critical role that is also played by Ca2+-permeable
AMPA receptors. AMPA receptors (AMPARs) are hetero-
meric assemblies of subunits GluR1– GluR4. AMPARs
lacking GluR2 subunits are permeable to Ca2+ and
Zn2+, can be blocked by intracellular polyamines, and ex-
hibit an inwardly rectifying current-voltage (I-V) relation.
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specified by the presence of an arginine (R) residue in
transmembrane domain 2 of this subunit instead of the
glutamine residue (Q) present in the GluR1, GluR3, and
GluR4 subunits. Although the vast majority of GluR2 sub-
units in the brain contain arginine at this site, this infor-
mation is not encoded at the genomic level but is the re-
sult of RNA editing of the GluR2 pre-mRNA in the nucleus
by the enzyme adenosine deaminase 2 (ADAR2), which
catalyzes site-selective deamination of adenosine in
the genomic glutamine codon (CAG) to an inosine, giving
an arginine codon (CIG) in the mRNA (Seeburg and Hart-
ner, 2003). This position is normally nearly 100% edited
in the brain, and so the vast majority of GluR2-contain-
ing AMPARs in the CNS contain GluR2(R) and are
Ca2+-impermeable. In addition, Q/R editing also influ-
ences assembly, membrane trafficking, and synaptic
targeting of GluR2-containing receptors (Seeburg and
Hartner, 2003; Greger et al., 2003). Two other ADAR
enzymes exist in mammals (ADAR1 and ADAR3), but
they play a negligible role in generating edited GluR2
subunits (Seeburg and Hartner, 2003).
The observation that GluR2 mRNA and protein are
specifically reduced in vulnerable CA1 pyramidal neu-
rons after transient ischemia led to the ‘‘GluR2 hypothe-
sis,’’ which proposed that decreased availability of
Ca2+-impermeable GluR2(R) protein after a neurological
insult would lead to increased formation of Ca2+-perme-
able AMPARs and consequently increased neurotoxic
Ca2+ (and possibly Zn2+) influx (Pellegrini-Giampietro
et al., 1997). In agreement with this, Lu and coworkers
recently demonstrated that AMPARs in CA1 pyramidal
cells exhibit an 18-fold greater permeability to Ca2+ after
an ischemic insult (Pellegrini-Giampietro et al., 1997; Liu
et al., 2004). In addition, using viral vectors to express
either GluR2(R) or GluR2(Q) in the hippocampus in vivo,
Liu et al. (2004) demonstrated that vulnerable hippo-
campal CA1 pyramidal cells could be rescued from
forebrain ischemic injury by overexpressing calcium-
impermeable GluR2(R) subunits, whereas expressing
calcium permeable GluR2(Q) subunits in normally ische-
mia-insensitive hippocampal dentate granule cells
resulted in degeneration of these cells after ische-
mia. This, in conjunction with work by other groups, pro-
vides substantial evidence to support a critical role for
Ca2+-permeable AMPARs in mediating ischemic cell
death. Remaining more controversial are the molecular
mechanisms that underlie the postischemic downregu-
lation of GluR2(R) protein and, in particular, the role of
GluR2 Q/R editing in this process (Pellegrini-Giampietro
et al., 1997; Seeburg and Hartner, 2003; Noh et al., 2005).
In this issue of Neuron, Peng et al. (2006) describe an
important additional step toward understanding the
mechanisms that increase AMPAR Ca2+ permeability
in vulnerable CA1 hippocampal cells after transient fore-
brain ischemia. Using a combination of electrophysiol-
ogy and single-cell RT-PCR, the authors correlated
GluR2 Q/R editing efficiency with the Ca2+ permeability
of AMPARs in single neurons. Postischemic CA1 pyra-
midal cells exhibited very high levels of heterogeneity
in Q/R editing (7%–98%) compared with sham controls
or other less-vulnerable hippocampal cell types (CA3
pyramidal or dentate granule cells), which all exhibited
over 95% editing efficiency, suggesting that GluR2Q/R editing in CA1 pyramidal neurons is particularly vul-
nerable to ischemic insult. Importantly, the impaired
GluR2 Q/R editing correlated closely with the Ca2+-per-
meability of AMPAR channels (assessed from the rever-
sal potential of the AMPAR current) in these cells. The
authors argue that a failure of previous studies to detect
alterations in levels of GluR2 Q/R editing in ischemia
may reflect the use of whole hippocampal tissue rather
than RNA derived from single electrophysiologically
characterised cells as in the current work (Pellegrini-
Giampietro et al., 1997). The authors then addressed
whether the decrease in GluR2 Q/R editing they ob-
served was due to an altered availability of the GluR2
RNA editing enzyme ADAR2. Using quantitative PCR,
they demonstrated that transient forebrain ischemia
dramatically decreased ADAR2 (but not ADAR1 or
ADAR3) mRNA levels in postischemic CA1 pyramidal
cells and that this closely correlated with reduced
GluR2 Q/R editing. Critically, the levels of ADAR2 in is-
chemia insensitive dentate granule and CA3 neurons re-
mained unaltered under the same conditions.
Based on these observations, the authors propose
that levels of ADAR2 play a crucial role in regulating the
postischemic formation of Ca2+-permeable AMPARs.
To confirm this, Peng et al. examined the consequences
of altering ADAR2 expression levels for GluR2 Q/R edit-
ing and AMPAR properties. Using adeno-associated
viral vectors to express ADAR2 in adult hippocampus
in vivo, the authors were able to return postischemic
GluR2 Q/R editing to normal (over 95%) levels in vulner-
able CA1 hippocampal cells, which resulted in postis-
chemic AMPARs that were Ca2+ impermeable. Viral
expression of ADAR2 was also found to be neuroprotec-
tive for vulnerable CA1 pyramidal cells. Conversely,
knockdown of hippocampal ADAR2 levels, with viral
vectors expressing small interfering RNA (siRNA), upre-
gulated Ca2+-permeable AMPARs (15-fold) in dentate
granule cells that usually express a Ca2+-impermeable
form of the receptor. Furthermore, ADAR2 knockdown
increased the sensitivity of CA1 pyramidal cells to ische-
mic injury and also increased postischemic cell death in
dentate granule and CA3 pyramidal neurons that are
usually insensitive to an ischemic insult. Importantly,
the postischemic neuronal degeneration caused by
ADAR2 knockdown in all cell types could be blocked
by virally coexpressing Ca2+-impermeable GluR2(R),
supporting the notion that ADAR2-dependent reduction
of GluR2(R) editing is a critical determinant of neuronal
vulnerability to an ischemic insult.
Finally, the authors showed that the postischemic
downregulation of ADAR2 levels in vulnerable CA1 neu-
rons is due to altered CREB-dependent transcriptional
regulation of ADAR2 because it could be blocked by vi-
rally expressing constitutively active VP16-CREB, which
restored GluR2 Q/R editing levels to over 90% and
blocked the formation of Ca2+-permeable AMPARs. Fur-
thermore, the authors demonstrated that ADAR2 activity
is required for CREB-dependent regulation of GluR2
Q/R site editing because siRNA ADAR2 knockdown in
the same cells expressing VP16-CREB was found to
override VP16-CREB-dependent protection of GluR2
Q/R editing levels, resulting in the generation of Ca2+-
permeable AMPARs. Taken together, these elegant
experiments present convincing evidence that the
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decreased CREB activity, leading to reduced ADAR2
expression, a switch in the ratio of edited to unedited
GluR2 Q/R subunits, and an increase in Ca2+ (and possi-
bly Zn2+) influx via Ca2+-permeable AMPARs.
Other mechanisms leading to a postischemic calcium
concentration rise, including Ca2+ entry via ASIC and
TRPM-7 channels and calpain-dependent inactivation
of the major Ca2+ extrusion pathway, have also been re-
cently reported (Aarts et al., 2003; Xiong et al., 2004;
Bano et al., 2005). The relative contribution to cell death
of the intracellular Ca2+ rise mediated by Ca2+-perme-
able AMPARs and that mediated by NMDARs or other
pathways needs to be further addressed. Ultimately,
ischemia-evoked death of CA1 pyramidal neurons is
caused by Ca2+ entry through NMDARs (Simon et al.,
1984; Lo et al., 2003; Wang et al., 2003). How does the
Ca2+ influx through AMPARs studied here control the
NMDAR-mediated Ca2+ influx? Based on previous work
by the same group, the authors propose that AMPAR-
mediated Ca2+ influx activates cyclin dependent kinase
5 (Cdk5), which phosphorylates serine 1232 on the
NR2A subunit of NMDA receptors and thus potentiates
NMDAR-mediated Ca2+ influx, specifically in CA1 neu-
rons (Wang et al., 2003). It is unclear why Ca2+ influx
through the NMDARs themselves could not cause this
potentiation. However, the fact that this potentiation is
specific to CA1 pyramidal neurons may in part explain
why activation of calcium-permeable AMPARs is neuro-
toxic in CA1 cells, whereas other neuronal types (such
as hippocampal interneurons) express Ca2+-permeable
AMPARs without deleterious effects (Pellegrini-Giam-
pietro et al., 1997).
The contribution to the increased formation of
Ca2+-permeable AMPARs of direct GluR2 transcriptional
downregulation, as opposed to the alteration in ADAR2-
dependent GluR2 Q/R editing described above, needs to
be investigated further. Others have recently demon-
strated that the transcriptional repressor REST is upre-
gulated after global ischemia, resulting in a suppression
of GluR2 promoter activity and GluR2 expression, which
is proposed to result in an almost complete switch to
Ca2+-permeable GluR2-lacking AMPARs (Noh et al.,
2005). In contrast, in the current study, the authors argue
that the postischemic reduction in ADAR2-dependent
GluR2 Q/R editing results in an accumulation of unedited
GluR2 pre-mRNA in the nucleus, which downregulates
both GluR2 mRNA and protein levels (Seeburg and
Hartner, 2003), but that the remaining GluR2(Q) protein
is preferentially assembled to produce Ca2+-permeable
AMPARs that are exported to synapses (Greger et al.,
2003). Further experiments are needed to address these
differences.
It will also be of interest to establish what cellular
mechanisms underlie the downregulation of CREB ac-
tivity in vulnerable neurons, which reduces ADAR2 gene
expression. One possibility is that calcium entry through
extrasynaptic NMDARs inhibits CREB (Hardingham
et al., 2002). It should be noted, however, that previous
studies have reported that the downregulation of GluR2
mRNA is not blocked by either AMPA or NMDA receptor
blockers (Pellegrini-Giampietro et al., 1997) but is
blocked by Ca2+EDTA (which chelates Zn2+) and anti-
sense knockdown of REST (Calderone et al., 2004;Noh et al., 2005). It will be interesting to test the effects
on postischemic ADAR2 gene expression of blocking
Ca2+ entry through NMDARs (or other sources of exter-
nal calcium) and of blocking other calcium-independent
signaling pathways.
The results of Peng et al. may have important implica-
tions for other neurological and psychiatric diseases in
which activation of Ca2+-permeable AMPAR-dependent
cell death mechanisms have been implicated in disease
etiology, such as epilepsy and amyotrophic lateral sclero-
sis (Pellegrini-Giampietro et al., 1997). In particular, the
recent observation of highly variable (0%–100%) GluR2
Q/R editing in motor neurons from ALS patients sug-
gests that altered CREB-dependent ADAR2 activity
may be a common mechanism in several neuronal dis-
eases (Kawahara et al., 2004). Thus, Ca2+-permeable
AMPARs or their RNA processing machinery may be
promising therapeutic targets for intervention in stroke
and other neurological diseases.
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